HE News Icon

HEOR News Roundup

Tuesday, Sept. 29, 2020 | Issue 521

email icon Twitter icon Facebook icon LinkedIn Icon Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

[Webinar] How Can Adaptive Designs and Master Protocols Enhance Your Oncology Trials?

While oncology trials comprise a large proportion of current research pipelines, conventional oncology development programs are frequently expensive, inefficient, and plagued by high failure rates.

Read More

ICER Condemns Monopoly Pricing of Trikafta Despite High Marks for Efficacy

COVID-19 Underscores Urgent Need for Real-world Data

Educating the Next Leaders in Applied HEOR: Jefferson’s Unique Approach

A Little More Spending Is Not the End of the World

HEOR news icon
Featured Events



Workshop: Digital Advances and Publication Planning: Current Practices and Future Directions

September 30


Maintaining Market Access Through a Pandemic; 6-months on

October 1


Syndicated Reports
HTA in Europe: Key Success Factors for Positive HTA Recommendations
Paying for Digital Health: Payer Insights
White Papers
Patient Centricity
How to Excel at Next Generation Trial Execution
  Analyst / Manager- Reimbursement Strategy Vice President/ Senior Vice President, Business Development Senior Analyst, Real World Evidence Solutions Research Associate III/Senior Research Associate – Data Collection – Peri- and Post-Approval Studies  

Share this newsletter!